| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930182AIT1263144B (en) | 1993-02-04 | 1993-02-04 | PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES |
| CA002155518ACA2155518A1 (en) | 1993-02-04 | 1994-02-02 | Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyarulonic acid combined with other pharmacologically active substances |
| PCT/EP1994/000294WO1994017840A1 (en) | 1993-02-04 | 1994-02-02 | Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances |
| KR1019950703218AKR960700766A (en) | 1993-02-04 | 1994-02-02 | Pharmaceutical composition consisting of sponge material in which ester derivative of hyaluronic acid is combined with other pharmaceutically effective substances |
| EP94906201AEP0682534A1 (en) | 1993-02-04 | 1994-02-02 | Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances |
| AU60014/94AAU6001494A (en) | 1993-02-04 | 1994-02-02 | Pharmaceutical compositions comprising a spongy material consisting of ester derivatives of hyaluronic acid combined with other pharmacologically active substances |
| JP6517622AJPH08506497A (en) | 1993-02-04 | 1994-02-02 | Pharmaceutical composition comprising a sponge-like material consisting of an ester derivative of hyaluronic acid in combination with other pharmaceutically active substances |
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI930182AIT1263144B (en) | 1993-02-04 | 1993-02-04 | PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES |
| Publication Number | Publication Date |
|---|---|
| ITMI930182A0 ITMI930182A0 (en) | 1993-02-04 |
| ITMI930182A1 ITMI930182A1 (en) | 1994-08-04 |
| IT1263144Btrue IT1263144B (en) | 1996-08-01 |
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ITMI930182AIT1263144B (en) | 1993-02-04 | 1993-02-04 | PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES |
| Country | Link |
|---|---|
| EP (1) | EP0682534A1 (en) |
| JP (1) | JPH08506497A (en) |
| KR (1) | KR960700766A (en) |
| AU (1) | AU6001494A (en) |
| CA (1) | CA2155518A1 (en) |
| IT (1) | IT1263144B (en) |
| WO (1) | WO1994017840A1 (en) |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5939323A (en)* | 1996-05-28 | 1999-08-17 | Brown University | Hyaluronan based biodegradable scaffolds for tissue repair |
| US6596703B1 (en) | 1997-07-11 | 2003-07-22 | Jagotec Ag | Promotion of wound healing utilizing steroids having reduced deteriorous systemic side effects typical of glucocorticoids, mineralocorticoids and sex steroids |
| US6872819B1 (en)* | 1998-05-27 | 2005-03-29 | Fidia Advanced Biopolymers S.R.L. | Biomaterials containing hyaluronic acid derivatives in the form of three-dimensional structures free from cellular components or products thereof for the in vivo regeneration of tissue cells |
| JP4273450B2 (en)* | 2000-12-07 | 2009-06-03 | 有限会社テクノサージ | Tissue regeneration substrate, transplant material, and production method thereof |
| CA2435491C (en) | 2001-01-31 | 2010-02-02 | Seikagaku Corporation | Crosslinked polysaccharide sponge |
| US7238677B2 (en)* | 2003-03-28 | 2007-07-03 | Kimberly-Clark Worldwide, Inc. | Prevention of urogenital infections |
| RU2369408C2 (en)* | 2004-07-09 | 2009-10-10 | Ферросан А/С | Hemostatic composition comprising hyaluronic acid |
| JP4754532B2 (en)* | 2007-07-09 | 2011-08-24 | 生化学工業株式会社 | A therapeutic agent containing hyaluronic acid oligosaccharide as an active ingredient |
| JP5569398B2 (en) | 2008-02-29 | 2014-08-13 | フェッローサン メディカル ディバイス エー/エス | Device for promoting hemostasis and / or wound healing |
| WO2013131520A2 (en) | 2012-03-06 | 2013-09-12 | Ferrosan Medical Devices A/S | Pressurized container containing haemostatic paste |
| CN104349797B (en) | 2012-06-12 | 2017-10-27 | 弗罗桑医疗设备公司 | Dry hemostatic composition |
| CA2912357C (en) | 2013-06-21 | 2019-12-31 | Ferrosan Medical Devices A/S | Vacuum expanded dry composition and syringe for retaining same |
| RU2678592C1 (en) | 2013-12-11 | 2019-01-30 | Ферросан Медикал Дивайсиз А/С | Dry composition comprising extrusion enhancer |
| JP6726852B2 (en) | 2014-10-13 | 2020-07-22 | フェッローサン メディカル ディバイス エー/エス | Dry composition for use in hemostasis and wound healing |
| CA2970710A1 (en) | 2014-12-24 | 2016-06-30 | Ferrosan Medical Devices A/S | Syringe for retaining and mixing first and second substances |
| EP3316930B1 (en) | 2015-07-03 | 2019-07-31 | Ferrosan Medical Devices A/S | Syringe for mixing two components and for retaining a vacuum in a storage condition |
| WO2019215274A1 (en) | 2018-05-09 | 2019-11-14 | Ferrosan Medical Devices A/S | Method for preparing a haemostatic composition |
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1229075B (en)* | 1985-04-05 | 1991-07-17 | Fidia Farmaceutici | Topical compsn. contg. hyaluronic acid deriv. as vehicle |
| US4851521A (en)* | 1985-07-08 | 1989-07-25 | Fidia, S.P.A. | Esters of hyaluronic acid |
| IT1219587B (en)* | 1988-05-13 | 1990-05-18 | Fidia Farmaceutici | SELF-CROSS-LINKED CARBOXYLY POLYSACCHARIDES |
| IT1248934B (en)* | 1990-06-01 | 1995-02-11 | Fidia Spa | BIOCOMPATIBLE PERFORATED MEMBRANES, PROCESSES FOR THEIR PREPARATION, THEIR USE AS A SUPPORT FOR THE IN VITRO GROWTH OF EPITHELIAL CELLS, ARTIFICIAL LEATHER THUS OBTAINED AND THEIR USE IN LEATHER TRANSPLANTS |
| IT1247472B (en)* | 1991-05-31 | 1994-12-17 | Fidia Spa | PROCESS FOR THE PREPARATION OF MICROSPHERES CONTAINING BIOLOGICALLY ACTIVE COMPONENTS. |
| IT1251151B (en)* | 1991-08-05 | 1995-05-04 | Fidia Spa | SPONGY MATERIAL ESSENTIALLY CONSTITUTED BY HYALURONIC ACID, OR ITS DERIVATIVES |
| IT1260154B (en)* | 1992-07-03 | 1996-03-28 | Lanfranco Callegaro | HYALURONIC ACID AND ITS DERIVATIVES IN INTERPENETRATING POLYMERS (IPN) |
| Publication number | Publication date |
|---|---|
| AU6001494A (en) | 1994-08-29 |
| WO1994017840A1 (en) | 1994-08-18 |
| KR960700766A (en) | 1996-02-24 |
| EP0682534A1 (en) | 1995-11-22 |
| CA2155518A1 (en) | 1994-08-18 |
| JPH08506497A (en) | 1996-07-16 |
| ITMI930182A0 (en) | 1993-02-04 |
| ITMI930182A1 (en) | 1994-08-04 |
| Publication | Publication Date | Title |
|---|---|---|
| IT1263144B (en) | PHARMACEUTICAL COMPOSITIONS INCLUDING SPONGY MATERIAL CONSTITUTED FROM FOREIGN DERIVATIVES OF HYALURONIC ACID IN ASSOCIATION WITH OTHER PHARMACOLOGICALLY ACTIVE SUBSTANCES | |
| FR2733427B1 (en) | INJECTABLE BIPHASIC COMPOSITIONS CONTAINING HYALURONIC ACID, ESPECIALLY USEFUL IN REPAIRING AND AESTHETIC SURGERIES | |
| CA2289717A1 (en) | Novel therapy for constipation | |
| BR9811827A (en) | Aqueous aerosol preparations containing biologically active macromolecules and process for the production of corresponding aerosols | |
| ES8507573A1 (en) | Hyaluronic acid fractions having pharmaceutical activity, methods for preparation thereof, and pharmaceutical compositions containing the same. | |
| DE3851152D1 (en) | CYCLOSPORINE EYE PRODUCTS. | |
| IT1265101B1 (en) | DERIVATIVES OF 2-AMINO-4-PHENYL-4-BUTYRIC BONE ACID | |
| ITMI920405A0 (en) | POLYSACRIC DERIVATIVES OF HEPARIN EPARAN SULFATE THEIR FRACTIONS AND FRAGMENTS PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| DK1167354T3 (en) | Racemic hypersensitivity A | |
| IT8920170A0 (en) | FLUORINATED DERIVATIVES OF BILE ACIDS, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
| CA2161774A1 (en) | Synthetic viscoelastic material for ophthalmic applications | |
| IT1263013B (en) | ESTERS OF L-CARNITINE AND ALCANOYL L-CARNITINE WITH GLYCOLIC ACID OR ITS ESTERS AND PHARMACEUTICAL COMPOSITIONS CONTAINING SUCH AS FOR THE TREATMENT OF SKIN DISEASES. | |
| BR9910329A (en) | Compound, pharmaceutical composition, process to stimulate the release of growth hormone from a mammal's pituitary, and use of a compound | |
| ATE254922T1 (en) | PHARMACEUTICAL COMPOSITIONS HAVING ANTIMICROBIAL ACTION | |
| CA2317465A1 (en) | Synthetic polysaccharides, their method of production and pharmaceutical compositions containing same | |
| PT862575E (en) | The invention relates to a process for preparing a pharmaceutical composition comprising | |
| RU95113437A (en) | Trans-2-dimethylamino-1-phenyl-3-cyclohexene-trans-1- carboxylic acid ±-ethyl ester as primary orthophosphate and solid pharmaceutical composition having pain-killing activity | |
| RU94000064A (en) | New 2-cyano-3-hydroxypropeneamides, method of preparing thereof, and pharmaceutical compositions containing said compounds | |
| IT1231723B (en) | PYROGLUTAMIC ACID DERIVATIVES, THEIR PREPARATIONS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| IT1281498B1 (en) | PYRAZOLE - DERIVATIVES WITH ANTI-CANCER ACTIVITY, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, AND | |
| EP2368984A1 (en) | Plasminogen activators having reduced lysine binding capacity | |
| IT1219567B (en) | FORSKOLINA DERIVATIVES, THEIR PROCEDURE AND PREPARATION INTERMEDIATES, THEIR APPLICATION AS MEDICATIONS AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| IT1270008B (en) | PURINIC AND 8-AZAPURINIC DERIVATIVES FOR THE THERAPEUTIC TREATMENT OF AIDS | |
| ITMI930013A0 (en) | DERIVATIVES OF 2-AZETIDINONE -1-SULFONIC ACID, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM | |
| SE8306792D0 (en) | NEUES THERAPEUTIC PREPARATION INCLUDING HYDRATED ERGOTAL CHALOID AND HEPARIN |
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted | ||
| TA | Fee payment date (situation as of event date), data collected since 19931001 | Effective date:19970227 |